Form 4: USANA COO Noot Reports RSU Vesting, Share Sales

Sentiment:

Insider Transaction Report


USANA Health Sciences Chief Operating Officer Walter Noot reported the vesting of restricted stock units and subsequent sales of shares to cover tax obligations.

Summary

  • Walter Noot, Chief Operating Officer of USANA Health Sciences Inc. (USNA), reported multiple transactions involving common stock and restricted stock units (RSUs).
  • On February 6, 2026, Noot acquired 3,375 shares of common stock upon the vesting of RSUs and disposed of 1,609 shares at $21.34 to cover tax liabilities.
  • On February 7, 2026, Noot acquired 1,705 shares of common stock from RSU vesting and disposed of 813 shares at $21.34 for tax purposes.
  • On February 8, 2026, Noot acquired 4,058 shares of common stock from RSU vesting and disposed of 1,738 shares at $21.34 for tax purposes.
  • Following these transactions, Noot beneficially owns 4,978 shares of common stock and 41,179 restricted stock units.
  • The RSUs represent a contingent right to receive one share of USNA common stock, with specific vesting schedules tied to February 6, 2023, February 7, 2022, and February 8, 2024 anniversaries.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While there are share sales, they are for tax purposes related to RSU vesting, indicating the successful execution of an executive compensation plan and an increase in the COO's overall beneficial ownership (including remaining RSUs).

Positives

  • The vesting of restricted stock units indicates the fulfillment of long-term incentive compensation for the Chief Operating Officer.
  • The acquisition of shares through RSU vesting increases the COO's direct ownership in the company, aligning management and shareholder interests.

Negatives

  • The disposition of shares to cover tax obligations reduces the immediate increase in the COO's direct beneficial ownership from the RSU vesting.

Industry Context

StockSavvy.ai notes that insider transactions, such as RSU vesting and subsequent tax-related sales, are common occurrences in publicly traded companies, particularly for executive compensation. These transactions reflect the standard operation of long-term incentive plans designed to align executive interests with shareholder value over time.

Stakeholder Impact

  • Shareholders: The vesting of RSUs and subsequent share ownership by the COO aligns management's interests with shareholder value. The tax-related sales are a standard part of executive compensation and generally not seen as a negative signal.

Key Dates

DateDescription
02/07/2022Anniversary date for 25% vesting of certain Restricted Stock Units.
02/06/2023Anniversary date for 25% vesting of certain Restricted Stock Units.
02/08/2024Anniversary date for 25% vesting of certain Restricted Stock Units.
02/06/2026Transaction date for RSU vesting and subsequent share disposition.
02/07/2026Transaction date for RSU vesting and subsequent share disposition.
02/08/2026Transaction date for RSU vesting and subsequent share disposition.
02/10/2026Signature date of the filing by Attorney-in-Fact.

Recommendation

hold

This Form 4 filing details routine insider transactions related to executive compensation (RSU vesting and tax-related sales). Such transactions are generally expected and do not typically provide new fundamental information that would warrant a change in investment recommendation. The filing confirms the ongoing operation of the company's long-term incentive plan for its Chief Operating Officer.

Keywords

USANA Health Sciences, USNA, Walter Noot, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Officer Transactions, Equity Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.